Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trinity Biotech PLC

0.6700
-0.0250-3.60%
Volume:37.45K
Turnover:25.36K
Market Cap:18.44M
PE:-0.29
High:0.6980
Open:0.6616
Low:0.6616
Close:0.6950
Loading ...
Nov 29, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 12, 2024

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Jun 27, 2024

Correspondence

Form CORRESP - Correspondence
May 03, 2024

Correspondence

Form CORRESP - Correspondence
May 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 30, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jan 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 02, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 17, 2023

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 25, 2022

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 23, 2022

Correspondence

CORRESP [Cover] - Correspondence